Plexus Corporation (
PLXS - Analyst Report) reported mixed fourth quarter 2011 financial results. The company beat the Zacks Consensus Estimate of $0.50 per share but fell shy of the revenue expectation of $540.0 million. Plexus continues to face cut-throat competition in the EMS market, where component shortages and supply chain constraints are increasing operational complexities.
Moreover, Plexus continues to invest in new sites and increasing headcount that may affect profitability in the near term. We maintain our Underperform rating and set a target price of $25.00.
Further, investment in Plexus is expected to generate just 10% over the next 5 years, compared to the peer group average of 11.5%. We therefore believe that downside potential exists.
Plexus Corporation (PLXS) : FULL ANALYST REPORT
|
Bear of the Day |
|
Every day we feature one stock with a Zacks Recommendation of Sell that is set to underperform over the next 6+ months. We also provide you with free access to the in-depth research report on the stock. If you would like to see all our Buy and Sell rated stocks and in-depth research reports, then check out Zacks Premium.
|
|
Read the full analyst report on PLXS